View in EDS HTML Full Text PDF Full Text

Can neurophysiologic measures serve as biomarkers for the efficacy of repetitive transcranial magnetic stimulation treatment of major depressive disorder?

Saved in:
Bibliographic Details
Title: Can neurophysiologic measures serve as biomarkers for the efficacy of repetitive transcranial magnetic stimulation treatment of major depressive disorder?
Authors: Kobayashi B; a David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; b Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; c Neuromodulation Division , Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles , Los Angeles , CA , USA., Cook IA; a David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; b Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; c Neuromodulation Division , Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles , Los Angeles , CA , USA.; d Department of Bioengineering , University of California Los Angeles , Los Angeles , CA , USA., Hunter AM; a David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; b Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; c Neuromodulation Division , Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles , Los Angeles , CA , USA., Minzenberg MJ; a David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; b Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; c Neuromodulation Division , Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles , Los Angeles , CA , USA., Krantz DE; a David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; b Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; c Neuromodulation Division , Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles , Los Angeles , CA , USA., Leuchter AF; a David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; b Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; c Neuromodulation Division , Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles , Los Angeles , CA , USA.
Source: International review of psychiatry (Abingdon, England) [Int Rev Psychiatry] 2017 Apr; Vol. 29 (2), pp. 98-114. Date of Electronic Publication: 2017 Mar 31.
Publication Type: Journal Article; Review
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918131 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1369-1627 (Electronic) Linking ISSN: 09540261 NLM ISO Abbreviation: Int Rev Psychiatry Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 28362541
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Can neurophysiologic measures serve as biomarkers for the efficacy of repetitive transcranial magnetic stimulation treatment of major depressive disorder?
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kobayashi+B%22">Kobayashi B</searchLink>; a David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; b Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; c Neuromodulation Division , Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles , Los Angeles , CA , USA.<br /><searchLink fieldCode="AU" term="%22Cook+IA%22">Cook IA</searchLink>; a David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; b Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; c Neuromodulation Division , Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles , Los Angeles , CA , USA.; d Department of Bioengineering , University of California Los Angeles , Los Angeles , CA , USA.<br /><searchLink fieldCode="AU" term="%22Hunter+AM%22">Hunter AM</searchLink>; a David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; b Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; c Neuromodulation Division , Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles , Los Angeles , CA , USA.<br /><searchLink fieldCode="AU" term="%22Minzenberg+MJ%22">Minzenberg MJ</searchLink>; a David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; b Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; c Neuromodulation Division , Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles , Los Angeles , CA , USA.<br /><searchLink fieldCode="AU" term="%22Krantz+DE%22">Krantz DE</searchLink>; a David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; b Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; c Neuromodulation Division , Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles , Los Angeles , CA , USA.<br /><searchLink fieldCode="AU" term="%22Leuchter+AF%22">Leuchter AF</searchLink>; a David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; b Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; c Neuromodulation Division , Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles , Los Angeles , CA , USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228918131%22">International review of psychiatry (Abingdon, England)</searchLink> [Int Rev Psychiatry] 2017 Apr; Vol. 29 (2), pp. 98-114. <i>Date of Electronic Publication: </i>2017 Mar 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Informa+Healthcare%22">Informa Healthcare </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8918131 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1369-1627 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209540261%22">09540261 </searchLink><i>NLM ISO Abbreviation: </i>Int Rev Psychiatry <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28362541
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/09540261.2017.1297697
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 98
    Titles:
      – TitleFull: Can neurophysiologic measures serve as biomarkers for the efficacy of repetitive transcranial magnetic stimulation treatment of major depressive disorder?
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kobayashi B
      – PersonEntity:
          Name:
            NameFull: Cook IA
      – PersonEntity:
          Name:
            NameFull: Hunter AM
      – PersonEntity:
          Name:
            NameFull: Minzenberg MJ
      – PersonEntity:
          Name:
            NameFull: Krantz DE
      – PersonEntity:
          Name:
            NameFull: Leuchter AF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2017 Apr
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1369-1627
          Numbering:
            – Type: volume
              Value: 29
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: International review of psychiatry (Abingdon, England)
              Type: main
ResultId 1